NEO
USDNeoGenomics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$10.200
Máximo
$10.317
Mínimo
$9.780
Volume
2.66M
Fundamentos da empresa
Capitalização de mercado
1.3B
Setor
Diagnostics & Research
País
United States
Estatísticas de negociação
Volume médio
3.47M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable
NeoGenomics Reports Third Quarter 2025 Results
Third quarter total revenue increased 12% YoY to $188 million Clinical revenue grew 18%, or 15% excluding the Pathline acquisition NGS revenue increased 24% YoY and now accounts for nearly one-third of clinical
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.